OC-0298 MLC tracking for lung cancer SABR is clinically feasible: results of first-in-human clinical trial
Booth, J., Caillet, V., Briggs, A., Hardcastle, N., Jayamanne, D., Szymura, K., Ricky, O., Eade, T., Keall, P.Volume:
133
Language:
english
Journal:
Radiotherapy and Oncology
DOI:
10.1016/s0167-8140(19)30718-2
Date:
April, 2019
File:
PDF, 468 KB
english, 2019